Currently, TRIM21 acts as tumor enhancer or suppressor depending on the cancer context by adversely influencing the crucial molecules in cancer progression, such as p53, Oct-1, Par-4, SALL4, SALL1, c-FLIP, BCL2, NF-κB, et al. [27]. The gene discussed is BCL2; the disease is cancer.